We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRSU
151
Pursuit Attractions and Hospitality Inc
PRSU
$1.4B
$1.72M 0.03%
+47,500
New +$1.61M
CRIS icon
152
Curis
CRIS
$8.67M
$1.62M 0.02%
48,910
+3,914
+9% +$136K
KMB icon
153
Kimberly-Clark
KMB
$36.6B
$1.59M 0.02%
+12,749
New +$1.65M
SPOT icon
154
Spotify
SPOT
$97.4B
$1.57M 0.02%
2,250
-566
-20% -$396K
MRVL icon
155
Marvell Technology
MRVL
$194B
$1.57M 0.02%
+18,621
New +$1.37M
GIS icon
156
General Mills
GIS
$19.1B
$1.54M 0.02%
+30,537
New +$1.53M
SCLX icon
157
Scilex Holding
SCLX
$46.4M
$1.3M 0.02%
+66,000
New +$1.12M
AFRM icon
158
Affirm
AFRM
$26.4B
$1.28M 0.02%
+17,536
New +$1.33M
PMN icon
159
ProMIS Neurosciences
PMN
$119M
$1.26M 0.02%
118,981
+33,465
+39% +$463K
CHWY icon
160
Chewy
CHWY
$9.78B
$1.25M 0.02%
+31,011
New +$1.2M
TKO icon
161
TKO Group
TKO
$13.5B
$1.22M 0.02%
+6,026
New +$1.1M
WATT icon
162
Energous
WATT
$101M
$1.2M 0.02%
+155,636
New +$1.48M
VIK icon
163
Viking Holdings
VIK
$48.2B
$1.18M 0.02%
+19,042
New +$1.14M
MDU icon
164
MDU Resources
MDU
$4.24B
$1.16M 0.02%
+65,152
New +$1.09M
MKC icon
165
McCormick & Company Non-Voting
MKC
$14.1B
$1.15M 0.02%
+17,147
New +$1.2M
PBH icon
166
Prestige Consumer Healthcare
PBH
$2.52B
$1.06M 0.02%
+16,960
New +$1.18M
MOBBW
167
Mobilicom Ltd Warrants
MOBBW
$2.33B
$1.05M 0.02%
242,100
– –
IPAR icon
168
Interparfums
IPAR
$3.93B
$993K 0.01%
+10,095
New +$1.19M
ED icon
169
Consolidated Edison
ED
$39.8B
$956K 0.01%
9,511
+5,497
+137% +$552K
BDX icon
170
Becton Dickinson
BDX
$48.7B
$938K 0.01%
+5,010
New +$931K
EMN icon
171
Eastman Chemical
EMN
$8.5B
$916K 0.01%
+14,530
New +$1.01M
WIX icon
172
WIX.com
WIX
$2.61B
$912K 0.01%
+5,136
New +$773K
CNK icon
173
Cinemark Holdings
CNK
$4.38B
$912K 0.01%
+32,549
New +$899K
TTWO icon
174
Take-Two Interactive
TTWO
$43.2B
$902K 0.01%
+3,492
New +$827K
UMBF icon
175
UMB Financial
UMBF
$11.2B
$897K 0.01%
+7,580
New +$874K
5 6
7
8 9

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.